文献速递临床免疫分子诊断质量管理与危急值

SARS-CoV-2感染血清学不同方法验证:IgA在感染早期的作用

SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection.
PubMed 文献 · Clin Chim Acta · 2020-09-28

该研究比较了一种化学发光免疫分析(CLIA)、两种酶联免疫吸附试验(ELISA)和一种电化学发光免疫分析(ECLIA)对SARS-CoV-2抗体的检测性能。结果显示ECLIA性能最佳,可作为筛查方法;ELISA检测的IgA可能比IgM更可靠稳定地作为早期血清学标志物,而IgG在症状出现10天后呈稳定水平。结论认为ECLIA可用于筛查,ELISA检测IgG和IgA可作为确认试验。

要点

  • ECLIA法检测SARS-CoV-2抗体性能最佳,适合作为筛查方法。
  • ELISA检测的IgA可能比IgM更可靠稳定地反映早期感染。
  • IgG在症状出现10天后水平稳定,ELISA检测IgG和IgA可用作确认试验。

核心结论

  • ECLIA法兼顾性能与单次检测成本,可作为SARS-CoV-2感染的筛查试验。
  • ELISA检测的IgG和IgA水平更高且持续时间更长,可能用作确认试验。

研究设计与样本

  • 研究测试并比较了一种化学发光免疫分析(CLIA)、两种酶联免疫吸附试验(ELISA)和一种电化学发光免疫分析(ECLIA)的性能。

主要发现

  • ECLIA血清学 assay 表现最佳,可能是SARS-CoV-2感染的有效筛查方法。
  • ELISA检测的IgA可能比IgM是更可靠和稳定的早期血清学标志物。
  • IgG在症状出现10天后如预期显示稳定水平。

临床怎么用

  • 可考虑将ECLIA法用于SARS-CoV-2感染的筛查。
  • ELISA检测IgG和IgA可用于确认试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: A novel coronavirus (SARS-CoV-2) was isolated from the respiratory samples of patients with pneumonia as showed by the sequence analysis of the virus genomes obtained in Wuhan, China. The antibody response to SARS-CoV-2 is not well understood yet, but the availability of sensitive and specific serological assays will be crucial for the early diagnosis of infection, for epidemiological studies and for defining the presence of neutralizing antibodies in response to a possible vaccine. MATERIALS AND METHODS: We tested and compared the performances of one chemiluminescent immunoassay (CLIA), two enzyme-linked immunosorbent assay (ELISA) and an electrochemiluminescence immunoassay (ECLIA). RESULTS: The ECLIA serological assay performed best and may be a valid screening method for SARS-COV-2 infection. The IgA detected by the ELISA assay might be a more reliable and stable early serological marker than IgM. Instead, IgGs, as expected, showed stable level after 10 days from symptoms onset. CONCLUSION: The ECLIA method could be used as screening test, considering both the excellent performance and the cost per single test; while ELISA assay for IgG and IgA, which are present at a higher level than IgM and last longer, might be used as confirmatory test.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Pieri M, Ciotti M, Carlozzi N, et al. SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. Clin Chim Acta. 2020. PMID: 33002475. doi:10.1016/j.cca.2020.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。